Lista de obras -

Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma

artículo científico publicado en 2014

Bone marrow biopsy in diffuse large B-cell lymphoma: useful or redundant test?

artículo científico publicado en 2014

CT-based versus FDG-PET/CT-based NCCN international prognostic index risk stratification in DLBCL.

artículo científico publicado en 2015

Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance

artículo científico publicado en 2015

Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?

artículo científico publicado en 2014

Does the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma?

artículo científico publicado en 2015

Effect of blind bone marrow biopsy on FDG-PET/CT interpretation of the posterior iliac crest in diffuse large B-cell lymphoma

scientific article published on 10 October 2014

False-negative FDG-PET in histologically proven extensive large cell bone marrow involvement in diffuse large B-cell lymphoma

artículo científico publicado en 2015

Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study

artículo científico publicado en 2015

Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG-PET.

artículo científico publicado en 2015

Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2015

Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma

artículo científico publicado en 2015

Prognostic value of tumor necrosis at CT in diffuse large B-cell lymphoma

artículo científico publicado en 2014

Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value?

artículo científico publicado en 2015

Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma

artículo científico publicado en 2015

Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study

artículo científico publicado en 2014

Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?

artículo científico publicado en 2015

Where Does Diffuse Large B-Cell Lymphoma Relapse?

artículo científico publicado en 2016

Lista de obras de

Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma

Bone marrow biopsy in diffuse large B-cell lymphoma: useful or redundant test?

CT-based versus FDG-PET/CT-based NCCN international prognostic index risk stratification in DLBCL.

Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance

Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?

Does the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma?

Effect of blind bone marrow biopsy on FDG-PET/CT interpretation of the posterior iliac crest in diffuse large B-cell lymphoma

False-negative FDG-PET in histologically proven extensive large cell bone marrow involvement in diffuse large B-cell lymphoma

Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study

Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG-PET.

Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma

Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma

Prognostic value of tumor necrosis at CT in diffuse large B-cell lymphoma

Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value?

Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma

Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study

Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?

Where Does Diffuse Large B-Cell Lymphoma Relapse?